Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China

Clinical Trial ID NCT00781378

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.	Chest	2009	3.23
2	Value of transthoracic echocardiography combined with cardiac troponin I in risk stratification in acute pulmonary thromboembolism.	Chin Med J (Engl)	2007	0.89
3	Value of right ventricular dysfunction for prognosis in pulmonary embolism.	Int J Cardiol	2007	0.87
4	Value of transthoracic echocardiography in therapy regimens evaluation in pulmonary embolism.	J Thromb Thrombolysis	2007	0.80
5	[Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].	Zhonghua Yi Xue Za Zhi	2007	0.75
6	Comparing different thrombolytic dosing regimens for treatment of acute pulmonary embolism.	Crit Care	2010	0.75
7	[Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population].	Zhonghua Yi Xue Za Zhi	2006	0.75
8	[Promoting the clinical and research work on pulmonary thromboembolism in China].	Zhonghua Jie He He Hu Xi Za Zhi	2004	0.75